目的探讨肝移植术后的免疫抑制疗法。
AIM To explore the immunosuppressive therapy for post liver transplantation.
一种胆碱酯酶抑制剂和免疫抑制疗法用于治疗。
A cholinesterase inhibitor (ChEI) and immunosuppressive therapy were applied for treatment.
有资料证实应用免疫抑制疗法减少了眼肌型患者进展成全身型的频率。
Some data show that immune depressive therapy can decrease the frequency of changes from ocular type to generalized type.
这个发现可能有助于确定能安全地减少或停止使用免疫抑制疗法的其他移植受者。
This finding may help identify other transplant recipients who could safely reduce or end use of immunosuppressive therapy.
因此一个理想的疗法应该具备以下几点：它是一个能防止潜在长期危险和排异反应并无需非特异型免疫抑制疗法的胰岛移植方案。
Thus, an optimal approach would involve an islet transplantation protocol that would prevent graft rejection without the need for potentially dangerous long-term and nonspecific immune suppression.
因此一个理想的疗法应该具备以下几点：它是一个能防止潜在长期危险和排异反应并无需非特异型免疫抑制疗法的胰岛移植方案。
Thus, an optimal approach would involve an islet transplantation protocol that would prevent graft rejection without the need for potentially dangerous long-term and nonspecific immune suppression.
应用推荐